Immunoassay Market By Products and Services (Instruments, Reagents & Kits, Software & Services), By Applications (Oncology, Infectious Disease Testing, Cardiology, Endocrinology, Autoimmune Disease, Other Applications), By End-users (Hospitals & Laboratories, Pharmaceutical & Biotechnology Companies, Other End-users), By Regions (North America, Europe, Asia Pacific, Rest of the World) – Global Forecast up to 2025

September 2019 | 110 pages | ID: IFC3F86CE227EN
IHR Insights

Abstracts

Global Immunoassay Market By Products and Services (Instruments, Reagents & Kits, Software & Services), By Applications (Oncology, Infectious Disease Testing, Cardiology, Endocrinology, Autoimmune Disease, Other Applications), By End-users (Hospitals & Laboratories, Pharmaceutical & Biotechnology Companies, Other End-users), By Regions (North America, Europe, Asia Pacific, Rest of the World) – Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025

This market research report includes a detailed segmentation of the global immunoassay market by products and services (instruments, reagents & kits, software & services), applications (oncology, infectious disease testing, cardiology, endocrinology, autoimmune disease, other applications), end-users (hospitals & laboratories, pharmaceutical & biotechnology companies, other end-users), and regions (North America, Europe, Asia Pacific, Rest of the World).

Overview of the Global Immunoassay Market

Infoholic’s market research report predicts that the “global immunoassay market” will grow at a CAGR of ~6.0% during the forecast period 2019–2025. Growing patient base, improvements in technology, increasing significance of companion diagnostics in the immunoassay market, launch of innovative products, and rising elderly population are few of the factors facilitating the growth of the immunoassay market.

The market continues to grow as immunoassay is one of the most widely used techniques for disease diagnosis and measuring treatment effectiveness. Key market players are focusing on increased product launch and strategic deals to strengthen their market position. The market generates significant revenue from the key players operating in this field, and few of them include Roche Diagnostics, bioM?rieux SA, Abbott Laboratories, Becton Dickinson & Company, and Siemens Healthineers.

According to Infoholic Research analysis, North America accounted for the largest share of the global immunoassay market in 2018 and Asia Pacific is expected to grow at a high CAGR during the forecast period. Immunoassays offer a broad array of applications in disease diagnosis with high specificity and sensitivity when compared to other tests. According to the National Cancer Institute, in the US, an estimated 1,735,530 new cancer cases were diagnosed and approximately 609,640 deaths were recorded in 2018. The biggest infectious disease killers, currently in the US, are pneumonia and flu, which are responsible for nearly 40% of all deaths from infectious diseases.

By Products and Services:

• Instruments
• Reagents and Kits
• Software and Services

Reagents and kits, in terms of immunoassay products and services, held a significant market share in 2018, owing to the need to repeat the purchase of assay kits & reagents, increase in the rate of chronic and infectious diseases, and growing number of immunoassay tests.

By Applications:

• Oncology
• Infectious Disease Testing
• Cardiology
• Endocrinology
• Autoimmune Disease
• Other Applications

Among various applications, the infectious disease testing segment occupied the largest share in 2018. Oncology is estimated to grow at a high CAGR during the forecast period due to increasing technological advancements that assist in the precise identification of cancer-causing organisms and rising number of cancer cases globally.

By End-users:

• Hospitals and Laboratories
• Pharmaceutical and Biotechnology Companies
• Other End-users

The hospitals and laboratories segment occupied the largest market share, i.e., more than 30% in 2018, and is expected to remain dominant during the forecast period 2019–2025.

By Regions:

• North America
• Europe
• Asia Pacific
• Rest of the World

North America was dominant in the global immunoassay market in 2018. The significant share of the North American region comes from the US due to improved healthcare infrastructure, high usage of immunoassays in clinical diagnostics, and favorable reimbursement facilities.

Immunoassay Market Research Competitive Analysis – The market is growing at a steady rate with mid-single-digit CAGR during the forecast period 2019–2025. The market players are continuously focusing on R&D to deliver innovative products in the market. The increasing usage of technology has resulted in strategic collaborations, new product launch, and increased funding. For instance, in March 2019, Beckman Coulter announced the launch of Access PCT assay, the newest addition to its extensive portfolio for the sepsis identification and management. In April 2019, Thermo Fisher Scientific announced the availability of the new immunoassay, Thermo Scientific CEDIA Mitragynine (Kratom) assay, its latest drugs of abuse test that comprises supporting calibrators and controls. In August 2019, Bio-Techne Corporation and Cygnus Technologies, a part of Maravai LifeSciences, announced a strategic partnership for the quantification of Chinese Hamster Ovary Host Cell Proteins (CHO-HCP) on the ProteinSimple-branded Ella immunoassay platform. According to agreement terms, both the companies are introducing the co-developed third-generation CHO-HCP assay in the proprietary Simple Plex immunoassay cartridge for customers in North America and Europe.

Key Vendors:

• Roche Diagnostics
• bioM?rieux SA
• Abbott Laboratories
• Becton Dickinson & Company
• Siemens Healthineers

Key Competitive Facts

• The market is highly competitive with all the players competing to gain market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.
• The requirement of high capital investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Benefits – The report provides complete details about the sub-segments of the global immunoassay market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the diagnostics segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:

• Understanding the potential market opportunity with precise market size and forecast data.
• A detailed market analysis focusing on the growth of immunoassay industry.
• Factors influencing the growth of the immunoassay market.
• In-depth competitive analysis of dominant and pure-play vendors.
• Prediction analysis of the immunoassay market in both developed and developing regions.
• Key insights related to major segments of the immunoassay market.
• Latest market trend analysis impacting the buying behavior of the consumers.

Contents

1 INDUSTRY OUTLOOK

1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends

2 REPORT OUTLINE

2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 MARKET SNAPSHOT

3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market
3.3 Industry Trends
3.4 Related Market
  3.4.1 Point-of-Care Diagnostics

4 MARKET OUTLOOK

4.1 Funding Scenario
4.2 Market Segmentation
4.3 Porter 5 (Five) Forces
4.4 PEST Analysis

5 MARKET CHARACTERISTICS

5.1 Market Dynamics
  5.1.1 Drivers
    5.1.1.1 Growing incidence of chronic and infectious disease
    5.1.1.2 Increase in geriatric population
    5.1.1.3 Growing adoption of immunoassay-based point-of-care diagnostics
  5.1.2 Restraints
    5.1.2.1 Stringent regulatory approval process of immunoassay instruments and consumables
    5.1.2.2 Unfavorable reimbursement scenario
  5.1.3 Opportunities
    5.1.3.1 Growing importance of companion diagnostics in the immunoassay market
    5.1.3.2 Market expansion opportunities in emerging economies
  5.1.4 DRO – Impact Analysis
5.2 Key Stakeholders

6 PRODUCTS AND SERVICES: MARKET SIZE AND ANALYSIS

6.1 Overview
6.2 Instruments
6.3 Reagents and Kits
6.4 Software & Services

7 APPLICATIONS: MARKET SIZE AND ANALYSIS

7.1 Overview
7.2 Oncology
7.3 Infectious Disease Testing
7.4 Cardiology
7.5 Endocrinology
7.6 Autoimmune Disease
7.7 Other Applications

8 END-USERS: MARKET SIZE AND ANALYSIS

8.1 Overview
8.2 Hospitals and Laboratories
8.3 Pharmaceutical and Biotechnology Companies
8.4 Other End-users

9 REGIONS: MARKET SIZE AND ANALYSIS

9.1 Overview
9.2 North America
  9.2.1 Overview
9.3 Europe
  9.3.1 Overview
9.4 Asia Pacific
  9.4.1 Overview
9.5 Rest of the World
  9.5.1 Overview

10 COMPETITIVE LANDSCAPE

11 VENDORS PROFILE

11.1 Roche Diagnostics
11.2 bioM?rieux SA
11.3 Abbott Laboratories
11.4 Becton Dickinson & Company
11.5 Siemens Healthineers

12 COMPANIES TO WATCH FOR

12.1 Danaher Corporation
12.2 Sysmex Corporation
12.3 Ortho Clinical Diagnostics
12.4 Thermo Fisher Scientific Inc.
12.5 Quidel Corporation
12.6 Qiagen
12.7 Bio-Rad Laboratories
12.8 PerkinElmer
Annexure
Abbreviations

List Of Tables

LIST OF TABLES

TABLE 1 GLOBAL IMMUNOASSAY MARKET REVENUE, BY PRODUCTS AND SERVICES, 2018–2025 ($BILLION)
TABLE 2 GLOBAL IMMUNOASSAY MARKET REVENUE, BY APPLICATIONS, 2018–2025 ($BILLION)
TABLE 3 GLOBAL IMMUNOASSAY MARKET REVENUE, BY GEOGRAPHY, 2018–2025 ($BILLION)
TABLE 4 BUSINESS SUMMARY: ROCHE DIAGNOSTICS
TABLE 5 BUSINESS SUMMARY: BIOM?RIEUX SA
TABLE 6 BUSINESS SUMMARY: ABBOTT LABORATORIES
TABLE 7 BUSINESS SUMMARY: BECTON DICKINSON & COMPANY
TABLE 8 BUSINESS SUMMARY: SIEMENS HEALTHINEERS
TABLE 9 BUSINESS SUMMARY: DANAHER CORPORATION
TABLE 10 BUSINESS SUMMARY: SYSMEX CORPORATION
TABLE 11 BUSINESS SUMMARY: ORTHO CLINICAL DIAGNOSTICS
TABLE 12 BUSINESS SUMMARY: THERMO FISHER SCIENTIFIC INC.
TABLE 13 BUSINESS SUMMARY: QUIDEL CORPORATION
TABLE 14 BUSINESS SUMMARY: QIAGEN N.V.
TABLE 15 BUSINESS SUMMARY: BIO-RAD LABORATORIES
TABLE 16 BUSINESS SUMMARY: PERKINELMER

List Of Figures

LIST OF FIGURES

CHART 1 RESEARCH METHODOLOGY OF GLOBAL IMMUNOASSAY MARKET
CHART 2 GLOBAL IMMUNOASSAY MARKET REVENUE, 2018–2025 ($BILLION)
CHART 3 PORTERS 5 FORCES ON IMMUNOASSAY MARKET
CHART 4 PEST ANALYSIS OF IMMUNOASSAY MARKET
CHART 5 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
CHART 6 DRO - IMPACT ANALYSIS
CHART 7 KEY STAKEHOLDERS
CHART 8 GLOBAL IMMUNOASSAY MARKET SHARE, BY PRODUCTS AND SERVICES, 2018 V/S 2025 (%)
CHART 9 INSTRUMENTS MARKET REVENUE, 2018–2025 ($BILLION)
CHART 10 REAGENTS AND KITS MARKET REVENUE, 2018–2025 ($BILLION)
CHART 11 SOFTWARE AND SERVICES MARKET REVENUE, 2018–2025 ($BILLION)
CHART 12 GLOBAL IMMUNOASSAY MARKET REVENUE, BY APPLICATIONS, 2018–2025 ($BILLION)
CHART 13 ONCOLOGY MARKET REVENUE, 2018–2025 ($BILLION)
CHART 14 INFECTIOUS DISEASE TESTING MARKET REVENUE, 2018–2025 ($BILLION)
CHART 15 CARDIOLOGY MARKET REVENUE, 2018–2025 ($BILLION)
CHART 16 ENDOCRINOLOGY MARKET REVENUE, 2018–2025 ($BILLION)
CHART 17 AUTOIMMUNE DISEASE MARKET REVENUE, 2018–2025 ($BILLION)
CHART 18 OTHER APPLICATIONS MARKET REVENUE, 2018–2025 ($BILLION)
CHART 19 GLOBAL IMMUNOASSAY MARKET REVENUE, BY END-USERS, 2018–2025 ($BILLION)
CHART 20 GLOBAL IMMUNOASSAY MARKET SHARE BY REGIONAL SEGMENTATION, 2018 V/S 2025 (%)
CHART 21 IMMUNOASSAY MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($BILLION)
CHART 22 IMMUNOASSAY MARKET REVENUE IN EUROPE, 2018–2025 ($BILLION)
CHART 23 IMMUNOASSAY MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($BILLION)
CHART 24 IMMUNOASSAY MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($BILLION)